These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
243 related articles for article (PubMed ID: 25701724)
1. The effects of A-803467 on cardiac Nav1.5 channels. Han Z; Jiang Y; Xiao F; Cao K; Wang DW Eur J Pharmacol; 2015 May; 754():52-60. PubMed ID: 25701724 [TBL] [Abstract][Full Text] [Related]
2. Inhibitory effects of hesperetin on Nav1.5 channels stably expressed in HEK 293 cells and on the voltage-gated cardiac sodium current in human atrial myocytes. Wang H; Wang HF; Zhang H; Wang C; Chen YF; Ma R; Xiang JZ; Du XL; Tang Q Acta Pharmacol Sin; 2016 Dec; 37(12):1563-1573. PubMed ID: 27694909 [TBL] [Abstract][Full Text] [Related]
3. Comparison of Gating Properties and Use-Dependent Block of Nav1.5 and Nav1.7 Channels by Anti-Arrhythmics Mexiletine and Lidocaine. Wang Y; Mi J; Lu K; Lu Y; Wang K PLoS One; 2015; 10(6):e0128653. PubMed ID: 26068619 [TBL] [Abstract][Full Text] [Related]
4. Tetrodotoxin-sensitive α-subunits of voltage-gated sodium channels are relevant for inhibition of cardiac sodium currents by local anesthetics. Stoetzer C; Doll T; Stueber T; Herzog C; Echtermeyer F; Greulich F; Rudat C; Kispert A; Wegner F; Leffler A Naunyn Schmiedebergs Arch Pharmacol; 2016 Jun; 389(6):625-36. PubMed ID: 27000037 [TBL] [Abstract][Full Text] [Related]
5. Inhibitory effects of hesperetin on Kv1.5 potassium channels stably expressed in HEK 293 cells and ultra-rapid delayed rectifier K(+) current in human atrial myocytes. Wang H; Wang HF; Wang C; Chen YF; Ma R; Xiang JZ; Du XL; Tang Q Eur J Pharmacol; 2016 Oct; 789():98-108. PubMed ID: 27397430 [TBL] [Abstract][Full Text] [Related]
6. Benzonatate inhibition of voltage-gated sodium currents. Evans MS; Maglinger GB; Fletcher AM; Johnson SR Neuropharmacology; 2016 Feb; 101():179-87. PubMed ID: 26386152 [TBL] [Abstract][Full Text] [Related]
7. Human stem cell-derived cardiomyocytes detect drug-mediated changes in action potentials and ion currents. Gibson JK; Yue Y; Bronson J; Palmer C; Numann R J Pharmacol Toxicol Methods; 2014; 70(3):255-67. PubMed ID: 25219538 [TBL] [Abstract][Full Text] [Related]
8. Modulation of peripheral Na(+) channels and neuronal firing by n-butyl-p-aminobenzoate. Thériault O; Poulin H; Sculptoreanu A; de Groat WC; O'Leary ME; Chahine M Eur J Pharmacol; 2014 Mar; 727():158-66. PubMed ID: 24486399 [TBL] [Abstract][Full Text] [Related]
9. Action potential changes associated with a slowed inactivation of cardiac voltage-gated sodium channels by KB130015. Macianskiene R; Bito V; Raeymaekers L; Brandts B; Sipido KR; Mubagwa K Br J Pharmacol; 2003 Aug; 139(8):1469-79. PubMed ID: 12922934 [TBL] [Abstract][Full Text] [Related]
10. Potent Inactivation-Dependent Inhibition of Adult and Neonatal NaV1.5 Channels by Lidocaine and Levobupivacaine. Elajnaf T; Baptista-Hon DT; Hales TG Anesth Analg; 2018 Sep; 127(3):650-660. PubMed ID: 29958221 [TBL] [Abstract][Full Text] [Related]
11. SCN5A variant that blocks fibroblast growth factor homologous factor regulation causes human arrhythmia. Musa H; Kline CF; Sturm AC; Murphy N; Adelman S; Wang C; Yan H; Johnson BL; Csepe TA; Kilic A; Higgins RS; Janssen PM; Fedorov VV; Weiss R; Salazar C; Hund TJ; Pitt GS; Mohler PJ Proc Natl Acad Sci U S A; 2015 Oct; 112(40):12528-33. PubMed ID: 26392562 [TBL] [Abstract][Full Text] [Related]
12. Antiarrhythmic effect of IKr activation in a cellular model of LQT3. Diness JG; Hansen RS; Nissen JD; Jespersen T; Grunnet M Heart Rhythm; 2009 Jan; 6(1):100-6. PubMed ID: 19121808 [TBL] [Abstract][Full Text] [Related]
13. A distinct molecular mechanism by which phenytoin rescues a novel long QT 3 variant. Gando I; Campana C; Tan RB; Cecchin F; Sobie EA; Coetzee WA J Mol Cell Cardiol; 2020 Jul; 144():1-11. PubMed ID: 32339567 [TBL] [Abstract][Full Text] [Related]
14. Intracellular calcium attenuates late current conducted by mutant human cardiac sodium channels. Potet F; Beckermann TM; Kunic JD; George AL Circ Arrhythm Electrophysiol; 2015 Aug; 8(4):933-41. PubMed ID: 26022185 [TBL] [Abstract][Full Text] [Related]
15. The cardiac sodium current Na(v)1.5 is functionally expressed in rabbit bronchial smooth muscle cells. Bradley E; Webb TI; Hollywood MA; Sergeant GP; McHale NG; Thornbury KD Am J Physiol Cell Physiol; 2013 Aug; 305(4):C427-35. PubMed ID: 23784541 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of Na Pabel S; Ahmad S; Tirilomis P; Stehle T; Mustroph J; Knierim M; Dybkova N; Bengel P; Holzamer A; Hilker M; Streckfuss-Bömeke K; Hasenfuss G; Maier LS; Sossalla S Basic Res Cardiol; 2020 Feb; 115(2):20. PubMed ID: 32078054 [TBL] [Abstract][Full Text] [Related]
17. A Comparative Analysis of Bupivacaine and Ropivacaine Effects on Human Cardiac SCN5A Channels. Schwoerer AP; Scheel H; Friederich P Anesth Analg; 2015 Jun; 120(6):1226-34. PubMed ID: 25692452 [TBL] [Abstract][Full Text] [Related]
19. Molecular basis of the inhibition of the fast inactivation of voltage-gated sodium channel Nav1.5 by tarantula toxin Jingzhaotoxin-II. Huang Y; Zhou X; Tang C; Zhang Y; Tao H; Chen P; Liu Z Peptides; 2015 Jun; 68():175-82. PubMed ID: 25817910 [TBL] [Abstract][Full Text] [Related]
20. Blocking Scn10a channels in heart reduces late sodium current and is antiarrhythmic. Yang T; Atack TC; Stroud DM; Zhang W; Hall L; Roden DM Circ Res; 2012 Jul; 111(3):322-32. PubMed ID: 22723299 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]